Literature DB >> 14997365

Quantitative structure-activity relationships of alpha1 adrenergic antagonists.

Slavica Eric1, Tomaz Solmajer, Jure Zupan, Marjana Novic, Marko Oblak, Danica Agbaba.   

Abstract

A quantitative structure-activity relationship study with respect to selectivity for alpha1 adrenoreceptor subtypes (alpha1a, alpha1b and alpha1d) of a wide series of structurally heterogeneous alpha1 adrenoreceptor antagonists has been performed. A large variety of molecular descriptors have been calculated and then analyzed by a heuristic method. The orthogonalization of the descriptors has been applied to build the QSAR equations. Ad hoc defined shape descriptors calculated by the Connolly algorithm with respect to reference supermolecules have also been considered in the rationalization of the mechanism of the activity of the ligands acting as antagonists on all three subtypes of alpha1 adrenoreceptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997365     DOI: 10.1007/s00894-003-0177-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  13 in total

Review 1.  Ligand design for alpha(1) adrenoceptors.

Authors:  J B Bremner; R Griffith; B Coban
Journal:  Curr Med Chem       Date:  2001-05       Impact factor: 4.530

2.  Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.

Authors:  D Barlocco; G Cignarella; V D Piaz; M P Giovannoni; P G De Benedetti; F Fanelli; F Montesano; E Poggesi; A Leonardi
Journal:  J Med Chem       Date:  2001-07-19       Impact factor: 7.446

3.  Theoretical descriptors in quantitative structure-affinity and selectivity relationship study of potent N4-substituted arylpiperazine 5-HT1A receptor antagonists.

Authors:  M C Menziani; P G De Benedetti; M Karelson
Journal:  Bioorg Med Chem       Date:  1998-05       Impact factor: 3.641

Review 4.  Molecular mechanisms involved in the activation and regulation of the alpha 1-adrenergic receptor subtypes.

Authors:  S Cotecchia; A Scheer; D Diviani; F Fanelli; P G De Benedetti
Journal:  Farmaco       Date:  1998-04

5.  Computer modeling of size and shape descriptors of alpha 1-adrenergic receptor antagonists and quantitative structure-affinity/selectivity relationships.

Authors:  M Montorsi; M C Menziani; M Cocchi; F Fanelli; P G De Benedetti
Journal:  Methods       Date:  1998-03       Impact factor: 3.608

6.  Alpha 1-adrenoceptor subtype selectivity: molecular modelling and theoretical quantitative structure-affinity relationships.

Authors:  P G De Benedetti; F Fanelli; M C Menziani; M Cocchi; R Testa; A Leonardi
Journal:  Bioorg Med Chem       Date:  1997-05       Impact factor: 3.641

7.  Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part II.

Authors:  R Testa; L Guarneri; P Angelico; E Poggesi; C Taddei; G Sironi; D Colombo; A C Sulpizio; D P Naselsky; J P Hieble; A Leonardi
Journal:  J Pharmacol Exp Ther       Date:  1997-06       Impact factor: 4.030

8.  Solvent-accessible surfaces of proteins and nucleic acids.

Authors:  M L Connolly
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

9.  Quantitative structure-activity relationship of flavonoid analogues. 3. Inhibition of p56lck protein tyrosine kinase.

Authors:  M Oblak; M Randic; T Solmajer
Journal:  J Chem Inf Comput Sci       Date:  2000 Jul-Aug

10.  Ligand design for alpha1 adrenoceptor subtype selective antagonists.

Authors:  J B Bremner; B Coban; R Griffith; K M Groenewoud; B F Yates
Journal:  Bioorg Med Chem       Date:  2000-01       Impact factor: 3.641

View more
  1 in total

1.  QSPR analysis of some agonists and antagonists of α-adrenergic receptors.

Authors:  Piotr Kawczak; Leszek Bober; Tomasz Bączek
Journal:  Med Chem Res       Date:  2014-07-15       Impact factor: 1.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.